Predicting Cancer Risk With Digital and Molecular Markers

Clinical trial NCT06962670 · RECRUITING

Trial details

NCT number: NCT06962670
Sponsor: University of Erlangen-Nürnberg Medical School
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Colorectal Cancer Gynecologic Cancer

Start date: 2024-09-14
Primary completion: 2025-09-01
Enrollment: 1250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.